You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 2, February 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  SPECIAL COMMUNICATION
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Potential for Adjuvant Radiotherapy in Choroidal Melanoma

Devron H. Char, MD; Theodore L. Phillips, MD

Arch Ophthalmol. 1982;100(2):247-248.


Abstract

• Controversy exists regarding the efficacy of enucleation in the management of choroidal melanoma. The effect of any form of ocular therapy on the prevalence of choroidal melanoma metastases is unknown. In a number of other systemic tumors, preoperative irradiation may lessen the occurrence of widespread disease. This type of therapeutic approach might be useful in the management of high-risk choroidal melanoma. In preliminary studies using 2,000 rad of preenucleation irradiation in patients with choroidal melanoma who have a poor prognosis, we have not observed notable morbidity. There are a number of limitations to the use of this adjunct therapy in choroidal melanoma management; however, a prospective national randomized trial of preenucleation irradiation in patients with high-risk choroidal melanoma might allow us to indirectly determine the effect of enucleation on the prevalence of choroidal melanoma metastases as well as delineate the potential role of this type of adjunct therapy in ocular melanoma.



Author Affiliations

From the Ocular Oncology Unit, Department of Ophthalmology, the Francis I. Proctor Foundation (Dr Char), and Department of Radiation Oncology (Dr Phillips), University of California, San Francisco.


Footnotes

Accepted for publication Sept 8, 1981.

Reprint requests to Director, Ocular Oncology Unit, Science 315, University of California, San Francisco, CA 94143 (Dr Char).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reduced Melanoma-Related Mortality in Uveal Melanoma by Preenucleation Radiotherapy
Kilic et al.
Arch Ophthalmol 2005;123:1363-1367.
ABSTRACT | FULL TEXT  

Comparison of Transillumination and Histologic Slide Measurements of Choroidal Melanoma
Umlas et al.
Arch Ophthalmol 1997;115:474-477.
ABSTRACT  

In Vitro Melanoma Cell Growth After Preenucleation Radiation Therapy
Kenneally et al.
Arch Ophthalmol 1988;106:223-224.
ABSTRACT  

Reduction of Enucleation-Induced Metastasis in Intraocular Melanoma by Periorbital Irradiation
Sanborn et al.
Arch Ophthalmol 1987;105:1260-1264.
ABSTRACT  

Standardized Echography in Uveal Melanomas With Scleral or Extraocular Extension
Farah et al.
Arch Ophthalmol 1984;102:1482-1485.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.